Parenteral aspirin produces and enhances gastric mucosal lesions and bleeding in rats
- PMID: 1080631
- DOI: 10.1007/BF01070953
Parenteral aspirin produces and enhances gastric mucosal lesions and bleeding in rats
Abstract
The effect of parenteral sodium acetylsalicylate (Na ASA) on the development of gastric mucosal lesions and bleeding was studied in control rats and in rats subjected to cold-restraint stress. Although both doses of Na ASA studied, 15 and 60 mg/kg intraperitoneally, alone resulted in lesion formation, only with the larger dose did this reach the level of statistical significance. However both doses of Na ASA alone significantly increased blood loss as measured by a decrease in hematocrit value. The administration of Na ASA 15 MG/kg intraperitoneally to animals subjected to cold-restraint significantly increased blood loss, but not lesion formation, while the larger dose of Na ASA significantly increased both parameters. Thus parenteral aspirin not only can cause gastric mucosal damage and bleeding, but it can enhance lesion formation and blood loss produced by cold-restraint. Two mechanisms may be involved: a smaller dose of Na ASA significantly affecting hemostasis but a larger dose being required for gastric mucosal damage.
Similar articles
-
Parenteral aspirin and sodium salicylate are equally injurious to the rat gastric mucosa.Gastroenterology. 1987 Oct;93(4):863-71. doi: 10.1016/0016-5085(87)90451-3. Gastroenterology. 1987. PMID: 3623027
-
Role of capsaicin-sensitive sensory nerves in gastroprotection against acid-independent and acid-dependent ulcerogens.Digestion. 1996 Nov-Dec;57(6):424-32. doi: 10.1159/000201371. Digestion. 1996. PMID: 8913705
-
Gastric adaptation to aspirin and stress enhances gastric mucosal resistance against the damage by strong irritants.Scand J Gastroenterol. 1996 Feb;31(2):118-25. doi: 10.3109/00365529609031974. Scand J Gastroenterol. 1996. PMID: 8658032
-
Lack of gastric toxicity of nitric oxide-releasing aspirin, NCX-4016, in the stomach of diabetic rats.Life Sci. 2000 Aug 18;67(13):1639-52. doi: 10.1016/s0024-3205(00)00746-3. Life Sci. 2000. PMID: 10983857
-
Aspirin and the stomach.Ann Intern Med. 1986 Mar;104(3):390-8. doi: 10.7326/0003-4819-104-3-390. Ann Intern Med. 1986. PMID: 3511824 Review.
Cited by
-
Letter: Gastrotoxic effect of parenteral aspirin.Am J Dig Dis. 1976 Sep;21(9):833. doi: 10.1007/BF01073041. Am J Dig Dis. 1976. PMID: 1085564 No abstract available.
-
IL33 Is a Stomach Alarmin That Initiates a Skewed Th2 Response to Injury and Infection.Cell Mol Gastroenterol Hepatol. 2015 Jan 3;1(2):203-221.e3. doi: 10.1016/j.jcmgh.2014.12.003. eCollection 2015 Mar. Cell Mol Gastroenterol Hepatol. 2015. PMID: 28210674 Free PMC article.
-
The role of aspirin in gastric ulceration . Some factors involved in the development of gastric mucosal damage induced by aspirin in rats exposed to various stress conditions.Am J Dig Dis. 1978 Jun;23(6):521-30. doi: 10.1007/BF01072696. Am J Dig Dis. 1978. PMID: 677107
-
Enhancement by intracerebroventricular thyrotropin-releasing hormone of indomethacin-induced gastric lesions in the rat.Br J Pharmacol. 1983 Dec;80(4):735-9. doi: 10.1111/j.1476-5381.1983.tb10065.x. Br J Pharmacol. 1983. PMID: 6443756 Free PMC article.
-
Gastric alarmin release: A warning signal in the development of gastric mucosal diseases.Front Immunol. 2022 Oct 6;13:1008047. doi: 10.3389/fimmu.2022.1008047. eCollection 2022. Front Immunol. 2022. PMID: 36275647 Free PMC article. Review.